News
SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Kambiz Rahbar discussing the utility of the PROSTest to predict response to 177 Lu-PSMA therapy in ...
SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Kambiz Rahbar discussing the clinical value of the PROSTest to detect biochemical recurrence in ...
AUA 2025 advanced prostate cancer, testosterone recovery profiles after cessation of androgen deprivation therapy (ADT), prostate cancer, testosterone levels following ADT cessation.
SNMMI 2025, Prostate Cancer, Three-Tier Risk Stratification of Prostate Cancer by PSMA-PET PROMISE (PPP2), 8Ga versus 18F-based PSMA radiotracers.
SNMMI 2025 phase I trial of 61Cu-NODAGA-PSMA I&T for prostate cancer patients, prostate PET imaging, 68Ga-PSMA-11, 18F-Piflulolastat (Pylarify), and 18F-Flotufolastat (Posluma), NODAGA-PSMA I&T.
Zachary Klaassen speaks with Adrien Holzgreve about the FLEX-MRT trial, which aims to personalize lutetium-177 PSMA radioligand therapy delivery. Currently, Pluvicto™ follows fixed dosing from the ...
PSMA PET prognosis, PROMISE registry, PSMA PET survival prediction, prostate cancer prognostic biomarker, PSMA PET risk stratification, Emerging Prognostic Value of Molecular Imaging in Prostate ...
Zachary Klaassen hosts Alessandro Viti to discuss early oncological outcomes in very high-risk prostate cancer patients using PSMA-PET imaging. Dr. Viti addresses the research question of how surgery ...
Philipp Backhaus presented first-in-human data on [⁶⁸Ga]Ga-OncoACP3-DOTA PET imaging, targeting prostatic acid phosphatase (ACP3), a novel and promising theranostic marker for prostate cancer.
ASCO 2025 HIF-2α targeting as a new frontier in renal cell cancer (RCC) therapy, Von Hippel-Lindau (VHL) gene mutation, LITESPARK-005, metastatic clear cell RCC. belzutifan.
(UroToday.com) The 2025 SNMMI annual meeting featured a prostate cancer and molecular imaging session and a presentation by Dr. Jiarou Wang discussing the first human study of 68 Ga-P17-079 in ...
(UroToday.com) The 2025 Interdisciplinary Genitourinary Cancer Forum featured a management of non muscle invasive bladder cancer session and a presentation by Dr. Bernard Bochner discussing clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results